Biomarkers, Cancer Therapy & Clinical Research

Psychiatric Biomarkers

Psychiatric biomarkers are essential indicators that support the diagnosis, treatment, and deeper understanding of mental health disorders such as depression, schizophrenia, and bipolar disorder. These biomarkers include a wide range of biological measures, such as neuroimaging patterns, neurotransmitter profiles, genetic variations, and inflammatory markers, which offer valuable insights into the neurobiological mechanisms underlying psychiatric conditions. Advances in neuroimaging technologies, including functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), allow researchers to visualize changes in brain structure, connectivity, and function associated with mental illness. Genetic and epigenetic biomarkers provide important information on disease susceptibility, progression, and individual responses to therapy. The application of psychiatric biomarkers enables personalized treatment strategies by predicting therapeutic efficacy and minimizing adverse effects. Additionally, these biomarkers support early diagnosis, disease monitoring, and preventive interventions.